دورية أكاديمية
أعرض في EDS

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial

التفاصيل البيبلوغرافية
العنوان: Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
المؤلفون: Fu, HaixiaAff1, Aff2, Aff3, Aff4, Sun, XueyanAff1, Aff2, Aff3, Aff4, Lin, Ren, Wang, YuAff1, Aff2, Aff3, Aff4, Xuan, Li, Yao, Han, Zhang, YuanyuanAff1, Aff2, Aff3, Aff4, Mo, XiaodongAff1, Aff2, Aff3, Aff4, lv, MengAff1, Aff2, Aff3, Aff4, Zheng, FengmeiAff1, Aff2, Aff3, Aff4, Kong, JunAff1, Aff2, Aff3, Aff4, Wang, FengrongAff1, Aff2, Aff3, Aff4, Yan, ChenhuaAff1, Aff2, Aff3, Aff4, Han, TingtingAff1, Aff2, Aff3, Aff4, Chen, HuanAff1, Aff2, Aff3, Aff4, Chen, YaoAff1, Aff2, Aff3, Aff4, Tang, FeifeiAff1, Aff2, Aff3, Aff4, Sun, YuqianAff1, Aff2, Aff3, Aff4, Chen, YuhongAff1, Aff2, Aff3, Aff4, Xu, LanpingAff1, Aff2, Aff3, Aff4, Liu, KaiyanAff1, Aff2, Aff3, Aff4, Zhang, XiAff5, IDs12916024032755_cor22, Liu, QifaAff6, IDs12916024032755_cor23, Huang, XiaojunAff1, Aff2, Aff3, Aff4, IDs12916024032755_cor24, Zhang, XiaohuiAff1, Aff2, Aff3, Aff4, IDs12916024032755_cor25
المصدر: BMC Medicine. 22(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17417015
DOI:10.1186/s12916-024-03275-5